Search the database for deliberate release of GM medicinal products
Displaying 1 - 1 of 1
| EU record number | Title | Company / Sponsor | Treated organism | Genetic modification |
|---|---|---|---|---|
| B/BE/03/B3 | Phase I multicentre study of TG1024 (Adenovirus interleukin 2) in patients with metastatic melanoma or other advanced solid tumor cancers | Transgene S.A. | Humans | gene coding for human interleukin 2 |